High-density lipoprotein--the clinical implications of recent studies.
about
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderlyRemodeling of HDL remnants generated by scavenger receptor class B type IA plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cellsEvaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteinsA molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activityIncreased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levelsApolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemiaObesity genotype score and cardiovascular risk in women with type 2 diabetes mellitusCould targeted food taxes improve health?AtherosclerosisA targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolismShotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLIdentification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type IGene therapy for lipid disordersPlasma lipid profiles and risk of cardiovascular disease in occupational lead exposure in Abeokuta, NigeriaStabilization of high-risk plaquesProteomics investigations of HDL: challenges and promiseFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewCysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional propertiesHealthy traditional Mediterranean diet: an expression of culture, history, and lifestyleEnhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptorsMultiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrationsEffects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteinsPharmaceutical cost savings of treating obesity with weight loss medicationsApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changesPersistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-IScavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor unMarked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-IMacrophage-independent regulation of reverse cholesterol transport by liver X receptors.Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmidsGenetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.Diabetic cardiovascular disease: getting to the heart of the matter.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.The water-soluble inclusion complex of ilexgenin A with β-cyclodextrin polymer--a novel lipid-lowering drug candidate.Statistical methods for the analysis of high-throughput metabolomics data.Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol.Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.Screening persons aged 65 and older for coronary heart disease risk factorsApolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1
P2860
Q23913851-2E5913AB-DE4F-48F5-A5FE-7E78BB7FFDAEQ24297431-184C2C56-B14F-4420-A670-A1F50529944FQ24336518-1AE047F1-2ACA-4A20-9306-C4AC69ED3355Q24533539-2163CC77-B984-4CBE-A978-8E488A3CC930Q24561532-DE8DD202-CD39-4B53-9F40-CC6F340C22C4Q24562095-B872F415-4542-4CC7-A5AC-0BB21C5693D8Q24633209-C219CEE7-C2F8-464E-AF87-FBF07A8FDE7BQ24633541-C91DC352-DF75-47C8-84FE-FCBF6B4FBEACQ24643428-1562CE36-CE7D-4083-80F4-24BCCB7E086AQ24644573-5413AECC-B6CA-4916-ADA3-8B3062FC09E6Q24646308-EEA8BA02-2BCA-4714-9F83-5D3602A82E03Q24669594-FAB4667C-54F9-4037-AF58-9B07E27AFCB9Q24673266-58691CB1-EB46-4B00-9571-CD1D7302032DQ24792755-E2E9AF53-19FB-48D5-BEBA-9A20BCC80ED1Q24810738-95D055D5-91B0-4357-B26A-6305D3E2056CQ26738584-8CA97088-4D9F-4F4B-BFB3-6625C58393D1Q27000995-93D2A52A-600E-4C5F-A3C2-E4D4FFA42A44Q28220294-FA0D8509-5560-40A6-979A-D75AA5499EA1Q28243134-18CFE380-11AF-46B6-8B71-C16D29DFA288Q28258277-20A96A6E-A478-4AD0-A611-F0D91229B203Q28268889-12F65C5A-7D10-4FD8-BF17-EF1D8655821AQ28288723-C43E469B-99C7-4578-A706-E84329FDAEFBQ28328142-15519B4D-70D3-43B0-9D58-CBE288E83BB7Q28376988-F4F80589-C4C7-4740-8FF2-19D1FEEFEFECQ28511491-128BBD85-7D6F-4156-B0D3-8A962CA0E2D5Q28570515-BF676287-E04E-4B1C-84ED-04C02DD02926Q28585282-901A6C7B-3CD3-4176-AD8E-EBB2F843BAA1Q28593554-1F1FABF6-6CFD-4534-AC8A-D4F89B2AB1FEQ28593920-16C1265A-DF78-4DA3-A150-368BE104CEBBQ30371540-4ED9D3DC-5A36-4C14-8BAD-1E6B5FF4E098Q30380038-BC27B5B8-301F-40B6-861A-E6F0A1A3DD21Q30444546-5554D5B7-3252-4F65-8BEE-1AC7C8911852Q30451529-CE2127BA-DD2C-477F-A398-4A5ED7B605C6Q30455490-2BA494E3-40AA-4135-A612-A8E947B4F5BAQ30650408-D0DF095A-D672-4444-9D49-39CBE7E3482EQ30790493-A24896F4-C2DB-42FD-AE17-70796B229834Q32068503-5FF8A064-6FCD-4648-80F7-82F2D01553C5Q33222417-719ECEE4-E181-4A8E-B27F-A77841200A41Q33559878-27CFAFEC-6365-46BA-8658-60020C3B3B8FQ33634131-87B211FC-0905-4D81-B9AF-02BF051F0893
P2860
High-density lipoprotein--the clinical implications of recent studies.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
High-density lipoprotein--the clinical implications of recent studies.
@en
type
label
High-density lipoprotein--the clinical implications of recent studies.
@en
prefLabel
High-density lipoprotein--the clinical implications of recent studies.
@en
P1476
High-density lipoprotein--the clinical implications of recent studies.
@en
P2093
P304
P356
10.1056/NEJM198911093211907
P407
P577
1989-11-01T00:00:00Z